Pentazocine-Suppository Paracetamol Versus Pentazocine-Suppository Diclofenac for Post-Caesarean Section Pain Relief: A Randomized Controlled Trial
Not Applicable
- Conditions
- Post-Caesarean section pain relief.
- Registration Number
- PACTR202407781417769
- Lead Sponsor
- MODUPEOLA IBRAHIM
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 288
Inclusion Criteria
All consenting parturient aged 18 years and above scheduled for elective or emergency Caesarean section under regional anesthesia
Exclusion Criteria
1.History of peptic ulcer disease
2.Patients who had Caesarean delivery under general anesthesia
3.History of hypersensitivity reaction to pentazocine, paracetamol or diclofenac
4.Severe Pre-eclampsia/Eclampsia
5.Renal and hepatic dysfunction
6.Patients who develop postoperative complications such as PPH
7.Any patient that will require special post-delivery pain control, such as sickle cell disease patients
8.Unconscious patient (GCS <=7)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The visual analogue pain score will be used to quantify post-operative pain management as the primary end measure
- Secondary Outcome Measures
Name Time Method patient satisfaction, the length of time an analgesic medication relieves pain, the need for rescue analgesia and unfavorable outcomes for mothers.